Want to join the conversation?
$ABT 2Q15 10-Q: Cash and cash equivalent at 2Q15-end was $4Bil, virtually unchanged from Dec. 31, 2014, as the cash generated by operations as well as the issuance of additional debt was offset by the impact of share repurchases and dividends paid. Net cash from operating activities for the 1H15 totaled $943MM.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.